Colorectal cancer biologic therapy studies
Colorectal cancer biologic therapy trials start with a conversation
Colorectal Biologic Trials lists colorectal cancer studies that test a biologic. That can be a vaccine, an antibody, or a cell or gene therapy. You can see which studies are recruiting and be connected with a study team. The first step is a short conversation. It costs nothing and carries no obligation.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed

Colorectal cancer biologic therapy studies in numbers
- colorectal cancer biologic therapy studies recruiting in the U.S.
- 43
- states with a study site
- 41
- cities with a study site
- 308
Source: ClinicalTrials.gov. Data processed .
Find colorectal cancer biologic therapy studies near you
These states have the most studies recruiting right now.
Texas
20 studies recruiting.
California
19 studies recruiting.
New York
15 studies recruiting.
Florida
13 studies recruiting.
Arizona
11 studies recruiting.
All locations
Browse every state and city with a recruiting study.
Colorectal cancer biologic therapy studies recruiting now
As of November 18, 2026, 43 colorectal cancer biologic therapy studies are recruiting participants in the United States, according to ClinicalTrials.gov. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry. This is what they have in common.
What they test
- biologics such as vaccines or antibodies43
- medications22
- procedures12
- other approaches4
- devices1
A study can test more than one.
Main purpose
- treating a condition42
- other purposes1
Phase
- Phase 117
- Phase 1/211
- Phase 27
- Phase 38
Who runs them
- industry22
- university, hospital or other13
- government8
Who they enroll
- adults (18 to 64)43
- older adults (65 and over)43
Where: sites in 41 states. The cities with the most are Houston, TX (15), Los Angeles, CA (13), New York, NY (13), Atlanta, GA (8), Grand Rapids, MI (8), Nashville, TN (8), San Antonio, TX (8), Aurora, CO (7).
These counts come from each study's public record and change as studies open and close. Browse every location to see what is recruiting near you.
Source: ClinicalTrials.gov. Data processed . Each bar shows a count as a share of all 43 studies.
Recently updated colorectal cancer biologic therapy studies
The 6 studies whose public records changed most recently, with some of the places each is recruiting. Select a study to read its full record on ClinicalTrials.gov.
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Recruiting in
- Allentown, PA · Ann Arbor, MI · Atlanta, GA · and 42 more U.S. locations
- Registry record
- NCT05863195 · updated
A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- SOTIO Biotech a.s.
- Recruiting in
- Fairfax, VA · Houston, TX
- Registry record
- NCT07693751 · updated
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Phase 2
- Ages 18 to 72
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Bethesda, MD
- Registry record
- NCT01174121 · updated
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Atlanta, GA · Baltimore, MD · Billings, MT · and 45 more U.S. locations
- Registry record
- NCT06997497 · updated
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Exelixis
- Recruiting in
- Bridgewater, NJ · Council Bluffs, IA · East Brunswick, NJ · and 11 more U.S. locations
- Registry record
- NCT07750158 · updated
Testing the Addition of Anti-cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment, Cetuximab Plus Encorafenib, for Colorectal Cancer
- Phase 1
- Ages 18 and older
- All sexes
- Sponsor
- National Cancer Institute (NCI)
- Recruiting in
- Aurora, CO · Charlottesville, VA · Columbus, OH · and 7 more U.S. locations
- Registry record
- NCT06102902 · updated
Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in the United States on ClinicalTrials.gov.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 18, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and some of the places it is recruiting) exactly as registered. Nothing in a record is reworded. This site lists only studies that test a biologic, such as a vaccine, an antibody, or a cell or gene therapy, as each study is coded in the registry.
Colorectal Biologic Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Not sure which study fits?
Tell a coordinator what you are looking for. They will explain which colorectal cancer biologic therapy studies may be worth a closer look and what the next step is. Asking does not commit you to anything.
What colorectal cancer biologic therapy studies look at
Every study listed here tests a biologic in colorectal cancer. A biologic can be a vaccine, an antibody, or a cell or gene therapy. Each study is built to answer one specific question. Because of that, what you would be asked to do varies between studies.
Whatever a study is testing is investigational. Researchers are still learning how well it works and what its risks are. That is why the study exists.
Who may be able to take part
Requirements are set separately for every colorectal cancer biologic trial. A trial may consider how old you are, your medical past, and the medicines you take now. It may also consider how you are affected by the condition. Certain trials are open to people without the condition as well.
Sorting out whether you fit is the study team's task, not yours. They review that when you come in for a screening visit. Read about eligibility and screening.
How taking part works
This process has four steps. Going on to the next one is your call every time.
Tell us what you are looking for
You begin with a call or a short form. You say which colorectal cancer biologic study, or kind of biologic, interests you.
Talk with a coordinator
You hear from a coordinator about the biologic trials that could fit you. Anything you ask gets a plain-language answer.
Meet the study team
This step happens only if you choose to go on. The study team goes over the trial with you point by point. Your eligibility is reviewed then too.
Decide what is right for you
Participation stays voluntary from start to finish. You may withdraw from a trial on any day, whatever your reason.
Why people take part in colorectal cancer biologic therapy studies
Reasons for joining a colorectal cancer biologic trial vary from person to person. Whatever yours is, it is worth talking through before you decide.
- Close health monitoring by a research team while the trial runs.
- A better understanding of colorectal cancer, for those living with it.
- A chance to contribute to research questions whose answers could influence future care for others.
Research and treatment are different things, and a trial is research. Nobody can tell you that joining will benefit you personally. Our page on what a clinical trial is explains this in simple terms.
Your safety and your rights come first
An independent ethics committee must review each trial before a single person can enroll. You are also given written details first, and only then asked to agree. Our guides explain the informed consent process and the review and monitoring of trials. They also set out the rights that stay with you throughout.
Common questions about colorectal cancer biologic therapy studies
Do I need a diagnosis to join a study about colorectal cancer?
Diagnosis rules differ from one colorectal cancer biologic trial to the next. Some trials want your diagnosis confirmed before you join. In other trials, staff assess you as part of screening. You will hear from the study team what applies in your case.
Would I have to change the care I receive now?
Please do not change any of your care by yourself. Some studies let current care continue. Others do not. The study doctor goes over this with you. You can also discuss it with your own doctor before you decide.
Is there a cost to take part?
In general, a participant pays nothing for trial visits, trial tests, or the biologic under study. See the full details on costs.
Does it cost anything to ask about a study?
No. There is no charge for a conversation with Colorectal Biologic Trials. A question is only a question, and it enrolls you in nothing.
Do I have to take part if I call?
No. Each stage goes ahead only if you choose it. Stopping is open to you whenever you want.
Who decides whether I can join a study?
Eligibility for a colorectal cancer biologic trial is decided by its study team. You attend a screening visit first, and their answer comes after it. Requirements are set separately for every trial. Read how screening works.
Ask about colorectal cancer biologic therapy studies
You begin by giving us some basic information. A coordinator then gets in touch. Asking creates no obligation of any kind.
Learn more from independent sources
- Colorectal Cancer — National Cancer Institute (NIH)
- What Are Clinical Trials? — National Cancer Institute (NIH)
- About Research Participation — HHS Office for Human Research Protections
- Learn About Studies — ClinicalTrials.gov (National Library of Medicine)